ArticlePharmacoEconomics2018

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.

Mark Bounthavong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.